The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

E.S. Leonova

Railway Clinical Hospital on the Station Gor’kiy, JSC Russian Railways, Inter Railway Center of Ophthalmology, 18 Lenina prospect, Nizhny Novgorod, Russian Federation, 603140;
Nizhny Novgorod State Medical Academy, 10/1 Minina i Pozharskogo Sq., Nizhny Novgorod, Russian Federation, 603950

S.V. Poliakov

GBOU "Rossiĭskiĭ gosudarstvennyĭ meditsinskiĭ universitet", kafedra obshchestvennogo zdorov'ia Moskovskogo fakul'teta

M.A. Pozdnyakova

«Privolzhsky Research Medical University» of the Ministry of Health of the Russian Federation, Nizhny Novgorod, Russia

Е.P. Yarygina

Nizhny Novgorod City Hospital No. 35, City Center of Glaucoma, 15 Osharskaya St., Nizhny Novgorod, Russian Federation, 603005

S.О. Semisynov

Nizhny Novgorod State Medical Academy, 10/1 Minina i Pozharskogo Sq., Nizhny Novgorod, Russian Federation, 603950

An experience with neuroprotective therapy of primary open-angle glaucoma based on the use of different dosage forms of Mexidol

Authors:

E.S. Leonova, S.V. Poliakov, M.A. Pozdnyakova, Е.P. Yarygina, S.О. Semisynov

More about the authors

Journal: Russian Annals of Ophthalmology. 2015;131(6): 91‑94

Views: 331

Downloaded: 10

To cite this article:

Leonova ES, Poliakov SV, Pozdnyakova MA, Yarygina ЕP, Semisynov SО. An experience with neuroprotective therapy of primary open-angle glaucoma based on the use of different dosage forms of Mexidol. Russian Annals of Ophthalmology. 2015;131(6):91‑94. (In Russ.)
https://doi.org/10.17116/oftalma2015131691-94

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.